Abstract
Reperfusion therapy has significantly improved survival and prognosis of patients with acute myocardial infarction. However, the development of heart failure, particularly in patients after a large myocardial damage, remains a major challenge. Cell therapy may provide a novel therapeutic option to modify left ventricular remodeling processes and prevent postinfarction heart failure. Experimental studies have suggested that the infusion of different subsets of bone marrow-derived progenitor cells, circulating endothelial progenitor cells, or tissue-residing stem cells improved neovascularization and cardiac function. Clinical studies at present predominantly used bone marrow mononuclear cells (BMNC) isolated from bone marrow aspirates by density gradient centrifugation. Intracoronary infusion of BMNC significantly increased global or regional ejection fraction and/or reduced infarct size and endsystolic volumes in patients with acute myocardial infarction as demonstrated in initial pilot trials and in randomized studies. We aim to review the existing evidence of the beneficial effect of BMNC infusion as well the controversial issues regarding this promising novel therapeutic approach.
Keywords: Cardiac regeneration, myocardial infarction, stem cells
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Cardiac Regeneration by Progenitor Cells: What Is It Known as and What Is It Still to Be Known as?
Volume: 7 Issue: 2
Author(s): Massimo F. Piepoli and Alessandro Capucci
Affiliation:
Keywords: Cardiac regeneration, myocardial infarction, stem cells
Abstract: Reperfusion therapy has significantly improved survival and prognosis of patients with acute myocardial infarction. However, the development of heart failure, particularly in patients after a large myocardial damage, remains a major challenge. Cell therapy may provide a novel therapeutic option to modify left ventricular remodeling processes and prevent postinfarction heart failure. Experimental studies have suggested that the infusion of different subsets of bone marrow-derived progenitor cells, circulating endothelial progenitor cells, or tissue-residing stem cells improved neovascularization and cardiac function. Clinical studies at present predominantly used bone marrow mononuclear cells (BMNC) isolated from bone marrow aspirates by density gradient centrifugation. Intracoronary infusion of BMNC significantly increased global or regional ejection fraction and/or reduced infarct size and endsystolic volumes in patients with acute myocardial infarction as demonstrated in initial pilot trials and in randomized studies. We aim to review the existing evidence of the beneficial effect of BMNC infusion as well the controversial issues regarding this promising novel therapeutic approach.
Export Options
About this article
Cite this article as:
Piepoli F. Massimo and Capucci Alessandro, Cardiac Regeneration by Progenitor Cells: What Is It Known as and What Is It Still to Be Known as?, Cardiovascular & Hematological Agents in Medicinal Chemistry 2009; 7 (2) . https://dx.doi.org/10.2174/187152509787847100
DOI https://dx.doi.org/10.2174/187152509787847100 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Current Pharmaceutical Biotechnology Infective Endocarditis Complicating Hypertrophic Obstructive Cardiomyopathy: Is Antibiotic Prophylaxis Really Unnecessary?
Current Cardiology Reviews Apoptosis in Anthracycline Cardiomyopathy
Current Pediatric Reviews Tumor Necrosis Factor Inhibitors from Poxviruses with An Emphasis on Tanapoxvirus-2L Protein
Recent Patents on DNA & Gene Sequences Editorial: Targeting Neuregulin1 and HER Receptor Tyrosine Kinases for Therapy of Breast Cancer and Heart Failure
Current Pharmaceutical Design Conserved Domains, Residues, WebLogo and Active Sites of Caspase- Cascades Related to Apoptotic Signaling Pathway
Current Bioinformatics Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease
Current Vascular Pharmacology Pharmacogenetic Variation and Metformin Response
Current Drug Metabolism Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Current Topics in Medicinal Chemistry New Therapies for Patients with Chronic Lymphocytic Leukemia
Current Cancer Therapy Reviews Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System
Current Pharmaceutical Biotechnology ULK1 Plays a Critical Role in AMPK-Mediated Myocardial Autophagy and Contractile Dysfunction following Acute Alcohol Challenge
Current Pharmaceutical Design Recent Patents and Advances on Isolation and Cellular Therapy Applications of Mesenchymal Stem Cells from Human Umbilical Cord Whartons Jelly
Recent Patents on Regenerative Medicine Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Preface: Facing New Challenges in Cardiovascular Disease, When the Pressure Goes Up and the Pump Goes Astray
Recent Advances in Cardiovascular Drug Discovery (Discontinued) New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry The Role of Redox Dysregulation in the Inflammatory Response to Acute Myocardial Ischaemia-reperfusion Injury - Adding Fuel to the Fire
Current Medicinal Chemistry Fluid Retention and Rostral Fluid Shift in Sleep-Disordered Breathing
Current Hypertension Reviews Towards More Efficient Glutathione Peroxidase Mimics: Substrate Recognition and Catalytic Group Assembly
Current Medicinal Chemistry Sinus Node If Channel Inhibition – A New Therapeutic Approach to Heart Rate Lowering
Current Drug Therapy